Showing results (71-80 of 138) with videos related to
Sort By:
Pageof 14
Antimicrobial Agents and Chemotherapy|November 1, 1996
Efficacy of ampicillin-sulbactam is not dependent upon maintenance of a critical ratio between components: sulbactam pharmacokinetics in pharmacodynamic interactionsM Alexov, P D Lister, C C SandersEuropean Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1993
Imipenem resistance in EnterobacterK S Thomson, C C Sanders, H ChmelInfection and Immunity|May 1, 1977
Bacterial interference. IV. Epidemiological determinants of the antagonistic activity of the normal throat flora against group A streptococciC C Sanders, G E Nelson, W E SandersAntimicrobial Agents and Chemotherapy|April 1, 1997
Importance of beta-lactamase inhibitor pharmacokinetics in the pharmacodynamics of inhibitor-drug combinations: studies with piperacillin-tazobactam and piperacillin-sulbactamP D Lister, A M Prevan, C C SandersAntimicrobial Agents and Chemotherapy|July 1, 1983
Influence of clindamycin on derepression of beta-lactamases in Enterobacter spp. and Pseudomonas aeruginosaC C Sanders, W E Sanders, R V GoeringThe Journal of Antimicrobial Chemotherapy|October 1, 1983
Effects of clindamycin on derepression of beta-lactamases in gram-negative bacteriaC C Sanders, W E Sanders, R V GoeringAntimicrobial Agents and Chemotherapy|December 1, 1978
Comparison of 5-episisomicin (Sch 22591), gentamicin, sisomicin, and tobramycin in treatment of experimental Pseudomonas infections in miceR V Goering, C C Sanders, W E SandersAntimicrobial Agents and Chemotherapy|June 1, 1982
In vitro antagonism of beta-lactam antibiotics by cefoxitinC C Sanders, W E Sanders, R V GoeringEuropean Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 1, 1995
Fluoroquinolone resistance in staphylococci: new challengesC C Sanders, W E Sanders, K S ThomsonAntimicrobial Agents and Chemotherapy|May 1, 1991
High-level resistance to cefotaxime and ceftazidime in Klebsiella pneumoniae isolates from Cleveland, OhioK S Thomson, C C Sanders, J A WashingtonPageof 14